What are the treatment options for migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Migraine Treatment Options

For acute migraine treatment, NSAIDs (aspirin 650-1000 mg, ibuprofen 400-800 mg, or naproxen 275-550 mg) and combination analgesics are first-line for mild to moderate attacks, while triptans are first-line for moderate to severe attacks, with triptan + NSAID combinations being most effective for severe attacks. 1

Acute Treatment Algorithm

Mild to Moderate Attacks

  1. First-line options:

    • NSAIDs:
      • Aspirin 650-1000 mg
      • Ibuprofen 400-800 mg
      • Naproxen sodium 275-550 mg
      • Paracetamol (acetaminophen) 650-1000 mg every 4-6 hours (max 4g/day) 1
    • Combination analgesics (acetaminophen + aspirin + caffeine) 1
  2. For attacks with significant nausea/vomiting:

    • Add antiemetics (metoclopramide or prochlorperazine)
    • Consider non-oral routes of administration 1

Moderate to Severe Attacks

  1. First-line options:

    • Triptans:
      • Sumatriptan (25-100 mg)
      • Rizatriptan
      • Zolmitriptan
      • Naratriptan 1, 2
    • Triptan + NSAID combination (most effective approach) 1
  2. Timing is crucial:

    • Start medication as soon as possible after migraine onset
    • Treating during mild pain phase provides better outcomes than waiting until pain is moderate/severe 3

Sumatriptan Efficacy

  • 50 mg and 100 mg doses show significant efficacy over placebo
  • 100 mg dose provides better pain-free response at 2 hours (NNT 4.7) compared to 50 mg dose (NNT 6.1) 3
  • Headache response rates at 2 hours: 50-62% for 100 mg dose vs 27% for placebo 2
  • Also effectively relieves associated symptoms (nausea, photophobia, phonophobia) 2, 3

Preventive Treatment

Consider preventive treatment if migraines occur ≥2 days per month with significant impact despite optimized acute treatment. 1

First-line Preventive Options

  1. Beta-blockers:

    • Propranolol (80-240 mg/day)
    • Timolol (20-30 mg/day) 1
  2. Antidepressants:

    • Amitriptyline (30-150 mg/day) - only antidepressant with consistent efficacy 1
  3. Anticonvulsants:

    • Topiramate (100 mg/day) - strongest evidence for chronic migraine
    • Divalproex sodium (500-1500 mg/day)
    • Sodium valproate (800-1500 mg/day) 1

Lifestyle Modifications

  • Regular sleep schedule
  • Consistent meal times
  • Adequate hydration
  • Regular exercise program (aerobic exercise 40 minutes, 3x weekly)
  • Progressive strength training (2-3x weekly, 30-60 minutes)
  • Stress management techniques (yoga, CBT, mindfulness)
  • Limited caffeine intake 1

Important Considerations and Cautions

Medication Overuse

  • Monitor for medication overuse headache (simple analgesics >15 days/month or triptans/combination analgesics >10 days/month) 1
  • Use headache diary to track medication use and effectiveness 1

Triptan Contraindications

  • Contraindicated in:
    • Coronary artery disease
    • Prinzmetal's variant angina
    • Wolff-Parkinson-White syndrome
    • History of stroke or TIA
    • Uncontrolled hypertension 2

Adverse Effects of Triptans

  • Common side effects include sensations of tightness, pain, pressure in chest/throat/neck/jaw
  • Risk of serotonin syndrome when combined with SSRIs, SNRIs, TCAs, or MAOIs
  • Can cause blood pressure elevation 2

When to Refer to Specialist

  • Uncertain diagnosis
  • Treatment ineffective despite appropriate interventions
  • Significant comorbidities complicating management
  • Medication overuse not manageable in primary care 1

Treatment Evaluation

  • Evaluate effectiveness after 2-3 months
  • For preventive treatments, allow 3-4 months to reach maximal efficacy
  • Consider changing medication if inadequate response 1

Remember that early intervention in acute attacks and appropriate preventive therapy in eligible patients are key principles for effective migraine management.

References

Guideline

Migraine Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Sumatriptan (oral route of administration) for acute migraine attacks in adults.

The Cochrane database of systematic reviews, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.